Achmea Investment Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-244,724
| Closed | -$18.4M | – | 169 |
|
|
2025
Q3 | $18.4M | Hold |
244,724
| – | – | 0.23% | 126 |
|
|
2025
Q2 | $16.9M | Buy |
244,724
+113,914
| +87% | +$7.47M | 0.22% | 119 |
|
|
2025
Q1 | $8.86M | Buy |
130,810
+24,667
| +23% | +$1.48M | 0.13% | 173 |
|
|
2024
Q4 | $4.76M | Sell |
106,143
-13,017
| -11% | -$730K | 0.08% | 222 |
|
|
2024
Q3 | $7.49M | Buy |
119,160
+1,935
| +2% | +$113K | 0.12% | 182 |
|
|
2024
Q2 | $6.92M | Sell |
117,225
-24,967
| -18% | -$1.56M | 0.12% | 185 |
|
|
2024
Q1 | $11.3M | Buy |
142,192
+8,196
| +6% | +$626K | 0.22% | 120 |
|
|
2023
Q4 | $10.6M | Sell |
133,996
-13,361
| -9% | -$951K | 0.22% | 112 |
|
|
2023
Q3 | $10.3M | Sell |
147,357
-64,664
| -30% | -$4.58M | 0.22% | 113 |
|
|
2023
Q2 | $14.7M | Buy |
212,021
+33,353
| +19% | +$2.37M | 0.31% | 79 |
|
|
2023
Q1 | $13.3M | Buy |
178,668
+4,039
| +2% | +$339K | 0.39% | 63 |
|
|
2022
Q4 | $15.2M | Buy |
174,629
+6,278
| +4% | +$606K | 0.51% | 40 |
|
|
2022
Q3 | $16.1M | Sell |
168,351
-10,284
| -6% | -$1.02M | 0.57% | 34 |
|
|
2022
Q2 | $16.6M | Sell |
178,635
-8,818
| -5% | -$861K | 0.54% | 35 |
|
|
2022
Q1 | $19M | Buy |
187,453
+17,211
| +10% | +$1.81M | 0.49% | 39 |
|
|
2021
Q4 | $17.6M | Buy |
170,242
+30,719
| +22% | +$2.84M | 0.83% | 21 |
|
|
2021
Q3 | $11.8M | Buy |
139,523
+17,875
| +15% | +$1.5M | 0.36% | 63 |
|
|
2021
Q2 | $10.2M | Sell |
121,648
-5,806
| -5% | -$475K | 0.35% | 66 |
|
|
2021
Q1 | $9.59M | Sell |
127,454
-29,722
| -19% | -$2.16M | 0.33% | 74 |
|
|
2020
Q4 | $10.7M | Buy |
157,176
+7,941
| +5% | +$517K | 0.39% | 53 |
|
|
2020
Q3 | $8.71M | Buy |
+149,235
| New | +$9.29M | 0.36% | 70 |
|
|
2020
Q1 | – | Sell |
-109,629
| Closed | -$8.14M | – | 326 |
|
|
2019
Q4 | $8.14M | Buy |
109,629
+17,078
| +18% | +$1.2M | 0.31% | 72 |
|
|
2019
Q3 | $5.84M | Hold |
92,551
| – | – | 0.23% | 111 |
|
|
2019
Q2 | $5.04M | Sell |
92,551
-40,605
| -30% | -$2.19M | 0.19% | 133 |
|
|
2019
Q1 | $7.18M | Sell |
133,156
-18,577
| -12% | -$1.15M | 0.3% | 79 |
|
|
2018
Q4 | $9.94M | Buy |
151,733
+15,676
| +12% | +$1.17M | 0.46% | 49 |
|
|
2018
Q3 | $10.7M | Sell |
136,057
-16,492
| -11% | -$1.18M | 0.41% | 57 |
|
|
2018
Q2 | $9.81M | Sell |
152,549
-30,526
| -17% | -$2.01M | 0.34% | 72 |
|
|
2018
Q1 | $11.4M | Buy |
183,075
+19,768
| +12% | +$1.42M | 0.38% | 68 |
|
|
2017
Q4 | $11.8M | Buy |
163,307
+66,602
| +69% | +$4.84M | 0.4% | 60 |
|
|
2017
Q3 | $7.86M | Buy |
96,705
+2,924
| +3% | +$231K | 0.45% | 49 |
|
|
2017
Q2 | $7.54M | Sell |
93,781
-44,736
| -32% | -$3.53M | 0.45% | 50 |
|
|
2017
Q1 | $10.9M | Buy |
+138,517
| New | +$11.1M | 0.51% | 36 |
|
Other funds holding CVS
Achmea Investment Management's CVS Position: Q4 2025 in Review
Achmea Investment Management sold out of CVS Health (CVS) in Q4 2025, closing a stake of 244,724 shares — an estimated $18.4M sold.
Achmea Investment Management first reported a position in CVS in Q1 2017 and held it in 33 quarters. The position peaked at $19M in Q1 2022. 1,948 funds tracked by Wall St. Rank hold CVS as of Q4 2025.
- Achmea Investment Management reported no remaining CVS Health position as of Q4 2025 after selling out during the quarter.
- Achmea Investment Management sold 244,724 CVS Health shares in Q4 2025, an estimated $18.4M.
- Achmea Investment Management first reported a position in CVS Health in Q1 2017 and held it in 33 quarters.
- Achmea Investment Management's CVS Health position peaked at $19M in Q1 2022.
- 1,948 funds tracked by Wall St. Rank held CVS Health as of Q4 2025.
Based on Achmea Investment Management's 13F filing for Q4 2025, filed 18 Feb 2026.